Mame Madjiguene Ka, Serigne Cheikh Tidiane Ndao, Waly Niang Mboup, Mariama Barry, Rabab Yassine, Pape Momar Guissé, Demba Waré Baldé, Tacko Niang, Djibril Marie Ba, Khadidiatou Dia, El Hadji Mbacké Sarr, Ibrahima Bara Diop, Mouhamed Chérif Mboup
{"title":"Global longitudinal strain in the prediction of significant coronary artery disease: how accurate is it for patients with a high clinical probability of chronic coronary syndrome and preserved left ventricular ejection fraction?","authors":"Mame Madjiguene Ka, Serigne Cheikh Tidiane Ndao, Waly Niang Mboup, Mariama Barry, Rabab Yassine, Pape Momar Guissé, Demba Waré Baldé, Tacko Niang, Djibril Marie Ba, Khadidiatou Dia, El Hadji Mbacké Sarr, Ibrahima Bara Diop, Mouhamed Chérif Mboup","doi":"10.1186/s44156-025-00084-1","DOIUrl":"10.1186/s44156-025-00084-1","url":null,"abstract":"<p><strong>Background: </strong>GLS is a non-invasive imaging test that can be useful in the selection of patients highly suspected of CCS for coronary angiogram.</p><p><strong>Aims: </strong>This study aimed to evaluate the diagnostic performance of rest 2D speckle tracking echocardiography (2D-STE) for detecting obstructive coronary artery disease (CAD) in patients with high clinical probability of chronic coronary syndrome (CCS) and preserved left ventricular ejection fraction (LVEF).</p><p><strong>Methods: </strong>A prospective study enrolled 52 patients referred for coronary angiography due to highly suspected CCS. Participants were divided into CAD+ (significant stenosis) and CAD- (normal or non-significant stenosis). Transthoracic echocardiography (TTE), exercise EKG, 2D-STE, and coronary angiography were performed. Global longitudinal peak systolic strain (GLS) was calculated using 2D-STE, with a cut-off value of -18% for normal GLS. Reproducibility was assessed with intraclass correlation.</p><p><strong>Results: </strong>The mean age of participants was 62.5 ± 11.9 years, and 63.5% were male. The CAD + group (51.9%) had significantly higher rates of hypertension, diabetes, dyslipidemia, and typical angina. GLS was significantly lower in the CAD + group (-15.89 ± 2.07%) compared to the CAD- group (-18.99 ± 2.37%, p = 0.0001). The optimal GLS cut-off for detecting significant coronary lesions was - 16.9%, with 74% sensitivity, 76% specificity, and an area under the curve (AUC) of 0.83 (95% CI 0.73-0.94). GLS correlated with the number of diseased vessels (p = 0.0001) but not with lesion complexity (SYNTAX score, p = 0.18). Regional strain was significantly reduced in patients with obstructive lesions in the left anterior descending (LAD) and circumflex arteries (CX), with optimal cut-offs at -19.2% and - 15.8%, respectively. GLS showed excellent inter-operator reproducibility (ICC = 0.94, p < 0.0001).</p><p><strong>Conclusion: </strong>GLS demonstrates good diagnostic performance in detecting obstructive CAD in patients with a high pre-test probability of CCS and preserved LVEF. It serves as a reliable, reproducible indicator of significant coronary lesions, with promising clinical utility for non-invasive CAD assessment, particularly in resource-limited settings.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"16"},"PeriodicalIF":3.2,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kylie J Hollitt, Steven Milanese, Majo Joseph, Rebecca Perry
{"title":"Can automation and artificial intelligence reduce echocardiography scan time and ultrasound system interaction?","authors":"Kylie J Hollitt, Steven Milanese, Majo Joseph, Rebecca Perry","doi":"10.1186/s44156-025-00077-0","DOIUrl":"10.1186/s44156-025-00077-0","url":null,"abstract":"<p><strong>Background: </strong>The number of patients referred for and requiring a transthoracic echocardiogram (TTE) has increased over the years resulting in more cardiac sonographers reporting work related musculoskeletal pain. We sought to determine if a scanning protocol that replaced conventional workflows with advanced technologies such as multiplane imaging, artificial intelligence (AI) and automation could be used to optimise conventional workflows and potentially reduce ergonomic risk for cardiac sonographers. The aim was to assess whether this alternate protocol could reduce active scanning time as well as interaction with the ultrasound machine compared to a standard echocardiogram without a reduction in image quality and interpretability.</p><p><strong>Method and results: </strong>Volunteer participants were recruited for a study that comprised of two TTE's with separate protocols. Both were clinically complete, but Protocol A combined automation, AI assisted acquisition and measurement, simultaneous and multiplane imaging whilst Protocol B reflected a standard scanning protocol without these additional technologies. Keystrokes were significantly reduced with the advanced protocol as compared to the typical protocol (230.9 ± 24.2 vs. 502.8 ± 56.2; difference 271.9 ± 61.3, p < 0.001). Furthermore, there was a reduction in scan time with protocol A compared to protocol B the standard TTE protocol (13.4 ± 2.3 min vs. 18.0 ± 2.6 min; difference 4.6 ± 2.9 min, p < 0.001) as well as a decrease of approximately 27% in the time the sonographers were required to reach beyond a neutral position on the ultrasound console.</p><p><strong>Conclusions: </strong>A TTE protocol that embraces modern technologies such as AI, automation, and multiplane imaging shows potential for a reduction in ultrasound keystrokes and scan time without a reduction in quality and interpretability. This may aid a reduction in ergonomic workload as compared to a standard TTE.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"11"},"PeriodicalIF":3.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12168272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clare M Culshaw, Daniel Augustine, Caroline J Coats, Ivo Andrade, Keith Pearce, Antonis Pantazis, William Bradlow, Lauren Turvey, William Moody, Lynne Williams, Rachel Bastianen, Jane Draper, David L Oxborough, Robert M Cooper
{"title":"British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inhibitor therapy.","authors":"Clare M Culshaw, Daniel Augustine, Caroline J Coats, Ivo Andrade, Keith Pearce, Antonis Pantazis, William Bradlow, Lauren Turvey, William Moody, Lynne Williams, Rachel Bastianen, Jane Draper, David L Oxborough, Robert M Cooper","doi":"10.1186/s44156-025-00078-z","DOIUrl":"10.1186/s44156-025-00078-z","url":null,"abstract":"","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"15"},"PeriodicalIF":3.2,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12128337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144200393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk factors for early radiation-induced heart damage in patients undergoing pulmonary SBRT.","authors":"Tingcui Li, Dan Zhu, Ming Cui","doi":"10.1186/s44156-025-00076-1","DOIUrl":"10.1186/s44156-025-00076-1","url":null,"abstract":"<p><strong>Background: </strong>Stereotactic body radiotherapy (SBRT) is superior to conventional radiotherapy for the treatment of lung tumors but can lead to radiation-induced heart damage (RIHD). Its risk factors have not been clarified. The purpose of our study was to determine the risk factors for early RIHD in patients undergoing pulmonary SBRT.</p><p><strong>Methods: </strong>We prospectively included patients who planned to receive pulmonary SBRT at our center from January 2020 to May 2021. Two-dimensional speckle tracking echocardiography was performed within 2 months after radiotherapy. The diagnostic criterion for early RIHD was a decrease in global longitudinal strain by ≥ 15% from baseline. Logistic regression was used to explore the risk factors for early RIHD.</p><p><strong>Results: </strong>A total of 108 patients were included in the study. The overall incidence of early RIHD in the cohort was 41.7%. Significant risk factors, including maximum heart dose, anthracycline use and hypertension, were independently associated with early RIHD, with ORs of 1.058 (95% CI: 1.028-1.089; p < 0.001), 3.524 (95% CI: 1.296-9.577; p = 0.014), and 4.284 (95% CI: 1.424-12.890; p = 0.010), respectively. The cutoff of the maximum heart dose was 27.0 Gy in patients who received anthracycline and 29.3 Gy in those who did not.</p><p><strong>Conclusions: </strong>Among patients receiving pulmonary SBRT, the maximum heart radiation dose, the use of anthracycline drugs and hypertension are independently associated with the occurrence of early RIHD. These findings could be applied to predict early RIHD and screen for high-risk patients. Individualized cardiac dose limitations may be helpful in improving the long-term prognosis of pulmonary SBRT patients.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"14"},"PeriodicalIF":3.2,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12128278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144200394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction: a meta-analysis of reconstructed time-to-event data.","authors":"Roozbeh Narimani-Javid, Mehrdad Mahalleh, Kiyarash Behboodi, Kasra Izadpanahi, Alireza Arzhangzadeh, Reza Nikfar, Seyed Ali Hosseini, Ehsan Amini-Salehi, Sasan Shafiei, Hamed Vahidi, Kaveh Hosseini, Hamidreza Soleimani","doi":"10.1186/s44156-025-00080-5","DOIUrl":"10.1186/s44156-025-00080-5","url":null,"abstract":"<p><strong>Background: </strong>The prognosis of Heart failure with preserved ejection fraction (HFpEF) is significantly impacted by the existence and severity of comorbidities. Recent studies highlight the right ventricle (RV) as a crucial player in heart failure pathophysiology. However, there are still gaps in understanding how right ventricular dysfunction (RVD) affects long-term outcomes in patients with heart failure with preserved ejection fraction (HFpEF).</p><p><strong>Materials and methods: </strong>In this systematic review and meta-analysis, a comprehensive search was conducted to identify studies investigating RVD as the predictor of the composite outcome of All-cause death, cardiac death, and hospitalization for HF in patients with HFpEF published until October 2024. RVD was defined as the deviation of at least one measurement of RV function from the recommended normal range based on modality and the normal ranges established in each study. Time and survival probability were extracted for each Group (HFpEF patients with and without RVD) in each of the Kaplan-Meier curves. Individual patient data were reconstructed by processing the extracted time points, survival probabilities, and the number of patients at risk in a two-stage approach. The restricted mean survival time (RMST) was also calculated as the area under the survival curve for each group.</p><p><strong>Results: </strong>Seven studies met the inclusion criteria, comprising 1936 individuals, of which 555 patients had RVD. The pooled prevalence of RVD among HFpEF was 41.2% (95% CI: 36.5; 45.9). Patients with RVD had a significantly higher risk of adverse outcomes compared to those without RVD, with an HR of 2.28 (95% CI, 1.95; 2.68, p-value < 0.001) in the eight-year follow-up after the RVD diagnosis. The one-year landmark analysis revealed that the majority of the event-free survival disparity between patients with RVD and those without arises from the first year after an RVD diagnosis. Patients with RVD also had shorter event-free survival. (ΔRMST = -2.127 years, 95% CI, -2.383; -1.872, p-value < 0.001).</p><p><strong>Conclusion: </strong>The development of RVD in HFpEF is linked to significantly increased composite outcomes of all-cause death and HF hospitalization and shorter event-free survival.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"13"},"PeriodicalIF":3.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144174071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephen P Juraschek, Noelle Ojo, Janet Monroe, Jordan B Strom, Jessica Stout, Warren J Manning, Ruth-Alma N Turkson-Ocran, Gabrielle Kolaci, Kaitlynn Geier, Carla Baptista, Araina Picanzo, Kenneth J Mukamal, Jason D Matos
{"title":"Standing transthoracic echocardiography: a feasibility study.","authors":"Stephen P Juraschek, Noelle Ojo, Janet Monroe, Jordan B Strom, Jessica Stout, Warren J Manning, Ruth-Alma N Turkson-Ocran, Gabrielle Kolaci, Kaitlynn Geier, Carla Baptista, Araina Picanzo, Kenneth J Mukamal, Jason D Matos","doi":"10.1186/s44156-025-00075-2","DOIUrl":"10.1186/s44156-025-00075-2","url":null,"abstract":"<p><strong>Background: </strong>Orthostatic hypotension (OH) is associated with cardiovascular disease, particularly among older adults. While a standing transthoracic echocardiogram (TTE) could theoretically identify changes in cardiac output to diagnose cardiogenic OH, there are no established protocols for orthostatic TTEs and their feasibility is unknown.</p><p><strong>Methods and results: </strong>We recruited 115 patients scheduled for elective outpatient TTE. Consenting participants, who were able to stand safely, underwent their scheduled recumbent TTE, followed by a standing TTE, performed within 1-2 minutes of standing. The focused TTE used the apical window to measure velocity time integral across the aortic valve to assess cardiac output. Blood pressure (BP) was measured in the supine and standing positions and patients were asked about symptoms of dizziness and lightheadedness. OH was defined as a change in standing minus supine systolic BP ≤-20 mm Hg or in diastolic BP of ≤-10 mm Hg. Of the 115 enrolled participants, 102 (89%) completed the standing echocardiogram protocol. Among those completing, mean age was 63.4 (SD, 14.8) years (38% were ≥ 70 years), 48% women, and 34% had a BMI ≥ 30 kg/m<sup>2</sup>. There were 21% with OH. Upon standing, systolic BP changed by -5.9 mm Hg (95% CI: -9.5, -2.2), diastolic BP by 2.4 mm Hg (-0.1, 4.8), and cardiac output by -0.4 L/min (95% CI: -0.7, -0.1). Change in cardiac output (per 1 L/min) was associated with a higher odds of systolic OH (OR: 1.60; 95% CI: 1.05, 2.42), but not diastolic OH (OR: 1.21; 95% CI: 0.63, 2.32).</p><p><strong>Conclusions: </strong>Standing TTE is safe, well-tolerated, and feasible in the ambulatory setting. Moreover, TTE changes in cardiac output are associated with systolic OH. This clinical assessment shows promise for distinguishing OH etiologies and could inform further research on treatments to prevent OH.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"12"},"PeriodicalIF":3.2,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Reza Kiani, Parisa Firoozbakhsh, Negar Dokhani, Azin Alizadehasl, Hooman Bakhshandeh, Ata Firouzi, Ali Zahedmehr, Mahnaz Daneshzadeh
{"title":"Comparing the impact of transcatheter ASD closure on echocardiographic indices in adults below and above 50 years.","authors":"Reza Kiani, Parisa Firoozbakhsh, Negar Dokhani, Azin Alizadehasl, Hooman Bakhshandeh, Ata Firouzi, Ali Zahedmehr, Mahnaz Daneshzadeh","doi":"10.1186/s44156-025-00074-3","DOIUrl":"https://doi.org/10.1186/s44156-025-00074-3","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter device closure is the method of choice for the closure of secundum atrial septal defects (ASD) with appropriate anatomic characteristics, leading to symptomatic relief, increased survival rates, cardiac remodeling, and improved cardiac function.</p><p><strong>Objective: </strong>Assessing the impact of transcatheter ASD closure on echocardiographic indices and comparing them between individuals younger and older than 50.</p><p><strong>Method: </strong>In this retrospective cohort study, 240 patients with isolated secundum ASD and complete documentation and follow-up data who underwent transcatheter device closure between 2015 and 2019 were included. Demographic, peri-procedural, and echocardiographic findings were compared before and after the procedure and among two age groups.</p><p><strong>Results: </strong>A total of 240 patients (68% female, 44% younger than 50) with a median age of 51 underwent transcatheter ASD closure. ASD closure led to a significant decline in the size of four cardiac chambers and systolic pulmonary arterial pressure (SPAP), in addition to a significant improvement in biventricular systolic function, LV diastolic function, and valvular insufficiencies. Although patients aged 50 and older had worse LV diastolic and RV systolic function, in addition to larger RV size and bi-atrial dimensions at the baseline, the extent of improvement of these parameters among them was significantly more pronounced than those younger than 50. There were no significant differences in the extent of the decline in SPAP between the two groups.</p><p><strong>Conclusion: </strong>Transcatheter ASD device closure is a beneficial procedure with high success rates and low complication rates among older individuals, eventually leading to improvements in cardiac form and function.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"10"},"PeriodicalIF":3.2,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144029788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
King Hei Dominic Cheng, Samir Sulemane, Sara Fontanella, Petros Nihoyannopoulos
{"title":"Right atrium area is associated with survival after out-of-hospital cardiac arrest: a single-center cohort study.","authors":"King Hei Dominic Cheng, Samir Sulemane, Sara Fontanella, Petros Nihoyannopoulos","doi":"10.1186/s44156-025-00072-5","DOIUrl":"https://doi.org/10.1186/s44156-025-00072-5","url":null,"abstract":"<p><strong>Background: </strong>Out-of-hospital cardiac arrest (OHCA) is associated with high mortality, highlighting the importance of identifying prognostic factors to guide treatment escalation plans. This study investigates the short-term prognostic potential of transthoracic echocardiogram (TTE), a commonly performed investigation in OHCA patients. This study is among the first to report left ventricle (LV) global longitudinal strain (LVGLS) in OHCA patients.</p><p><strong>Methods: </strong>This single-center retrospective cohort study included 54 patients treated between 2019 and 2022, during the COVID-19 pandemic. Patient characteristics were reported using the 2015 Utstein template, and echocardiographic parameters were assessed following British Society of Echocardiography guidelines. Univariate analyses compared TTE parameters by survival-to-discharge and implantable cardioverter-defibrillator implantation outcomes. Correlations between LV ejection fraction (LVEF) derived from cardiac magnetic resonance imaging (cMRI) and echocardiographic LV systolic parameters were evaluated.</p><p><strong>Results: </strong>The survival-to-discharge rate was 77.8%. Non-survivors had a significantly larger right atrium (RA) area (RAA) (20.8 cm<sup>2</sup> vs. 15.2 cm<sup>2</sup> in survivors; p = 0.003). No statistically significant differences were observed for other right or left heart parameters. The median LVGLS was reduced at -11.4% (interquartile range: -14.0 to -7.6). LVEF correlates well on cMRI and TTE (Pearson correlation coefficient = 0.830).</p><p><strong>Conclusion: </strong>This study identifies a novel association between larger RAA and short-term mortality following OHCA, alongside a higher survival rate in a tertiary center. Further research should consider incorporating RA parameters into analyses to refine prognostic assessments.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"9"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11995584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Virginia Zarama, Carlos E Vesga, John Balanta-Silva, Mario M Barbosa, Jaime A Quintero, Ana Clarete, Paula A Vesga-Reyes, Juan Carlos Silva Godinez
{"title":"Complication rates in real-time ultrasound-guided vs static echocardiography-guided pericardiocentesis: a cohort study.","authors":"Virginia Zarama, Carlos E Vesga, John Balanta-Silva, Mario M Barbosa, Jaime A Quintero, Ana Clarete, Paula A Vesga-Reyes, Juan Carlos Silva Godinez","doi":"10.1186/s44156-025-00071-6","DOIUrl":"10.1186/s44156-025-00071-6","url":null,"abstract":"<p><strong>Background: </strong>Static echocardiography-guided pericardiocentesis, the current standard of care, uses a phased-array probe to locate the largest fluid pocket, marking the safest entry site and needle trajectory. Nevertheless, real-time needle visualization throughout the procedure would potentially increase success and decrease complications. The aim of this study was to assess the complication rates of the real-time in-plane ultrasound-guided technique compared to the traditional static echocardiography-guided pericardiocentesis.</p><p><strong>Methods: </strong>All adult patients who underwent pericardiocentesis in a tertiary care hospital from January 2011 to June 2024 were identified. The incidence of total complications of the real-time, in-plane, US-guided pericardiocentesis versus the static echocardiography-guided technique was compared using a regression model with overlap weighting, based on propensity scores, to adjust for confounding factors.</p><p><strong>Results: </strong>A total of 220 pericardiocentesis were identified, 91 with real-time, in-plane US-guided technique and 129 with a static echo-guided approach. The overall rate of total complications was 5.5%, with no significant difference between both techniques (IRR 1.06 [95% CI 0.98 to 1.16, p = 0.163]). Only one major complication was reported with the in-plane technique (pulmonary edema) compared to four major complications in the echo-assisted approach (three cardiac injuries and one injury to thoracic vessels), all of which required emergency surgery. The success rate was higher in the real-time in-plane US-guided procedures (97%) compared to the static echo-guided approach (93%).</p><p><strong>Conclusions: </strong>In this single-center retrospective cohort study, real-time in-plane, US-guided pericardiocentesis technique was safe, and the rate of total complications was not significantly different from a static echo-guided approach. The low rate of major complications and high success rate underscores the potential use of this technique in emergency situations by well-trained physicians. Future studies are warranted to thoroughly assess the potential benefits of the real-time approach.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"8"},"PeriodicalIF":3.2,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11959931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Oxborough, Keith George, Robert Cooper, Raghav Bhatia, Tristan Ramcharan, Abbas Zaidi, Sabiha Gati, Keerthi Prakash, Dhrubo Rakhit, Shaun Robinson, Graham Stuart, Jan Forster, Melanie Ackrill, Daniel Augustine, Aneil Malhotra, Michael Papadakis, Silvia Castelletti, Victoria Pettemerides, Liam Ring, Antoinette Kenny, Aaron Baggish, Sanjay Sharma
{"title":"Echocardiography in the cardiac assessment of young athletes: a 2025 guideline from the British Society of Echocardiography (endorsed by Cardiac Risk in the Young).","authors":"David Oxborough, Keith George, Robert Cooper, Raghav Bhatia, Tristan Ramcharan, Abbas Zaidi, Sabiha Gati, Keerthi Prakash, Dhrubo Rakhit, Shaun Robinson, Graham Stuart, Jan Forster, Melanie Ackrill, Daniel Augustine, Aneil Malhotra, Michael Papadakis, Silvia Castelletti, Victoria Pettemerides, Liam Ring, Antoinette Kenny, Aaron Baggish, Sanjay Sharma","doi":"10.1186/s44156-025-00069-0","DOIUrl":"10.1186/s44156-025-00069-0","url":null,"abstract":"<p><p>Sudden cardiac death in a young physically active individual or athlete is a rare but tragic event. Pre-participation screening and follow-up investigations are utilised to reduce the risk and occurrence of these events. Echocardiography plays a key role in the cardiac diagnostic pathway and aims to identify underlying inherited or congenital structural cardiac conditions. In 2013 the British Society of Echocardiography and Cardiac Risk in the Young produced a joint guidance document to support echocardiographers in this setting. The document was subsequently updated in 2018, and it is now timely to provide a further update to the guideline drawing on the advances in our knowledge alongside the developments in ultrasound technology within this nuanced area of sports cardiology.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"12 1","pages":"7"},"PeriodicalIF":4.4,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11907977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143626434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}